newsfilter
← Latest News
PR Newswire·

Medivir to present at the Redeye Life Science Day

STOCKHOLM, Nov. 16, 2022 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the